News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Alam Kamran
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/25/2023 |
4
| Alam Kamran (CFO) has filed a Form 4 on Taysha Gene Therapies, Inc.
Txns:
| Sold 33,000 shares
@ $2.33, valued at
$76.9k
|
|
08/24/2023 |
144
| Form 144 - Report of proposed sale of securities: |
02/06/2023 |
4
| Alam Kamran (CFO) has filed a Form 4 on Taysha Gene Therapies, Inc.
Txns:
| Granted 18,691 shares
@ $0 Granted 37,384 options to buy
@ $1.18, valued at
$44.1k
Granted 149,900 options to buy
@ $1.18, valued at
$176.9k
|
|
08/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/08/2022 |
4
| Alam Kamran (CFO) has filed a Form 4 on Taysha Gene Therapies, Inc.
Txns:
| Granted 40,000 options to buy
@ $6.52, valued at
$260.8k
|
|
02/25/2022 |
4
| Alam Kamran (CFO) has filed a Form 4 on Taysha Gene Therapies, Inc.
Txns:
| Granted 80,000 options to buy
@ $5.96, valued at
$476.8k
|
|
08/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/20/2021 |
4
| Alam Kamran (CFO) has filed a Form 4 on Taysha Gene Therapies, Inc.
Txns:
| Granted 70,000 options to buy
@ $31, valued at
$2.2M
|
|
09/25/2020 |
4
| Alam Kamran (CFO) has filed a Form 4 on Taysha Gene Therapies, Inc.
Txns:
| Granted 331,121 shares
@ $0 |
|
09/23/2020 |
3
| Alam Kamran (CFO) has filed a Form 3 on Taysha Gene Therapies, Inc. |
02/10/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/06/2019 |
4
| Alam Kamran (SVP - Finance & PFO) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.
Txns:
| Granted 200,000 options to buy
@ $14.25, valued at
$2.9M
|
|
11/06/2019 |
3
| Alam Kamran (SVP - Finance & PFO) has filed a Form 3 on ROCKET PHARMACEUTICALS, INC. |
|
|